Pull to refresh
Logo
Vaxart

Vaxart

Biotechnology company

Appears in 1 story

Stories

Moderna's norovirus vaccine misses an early-success mark in Phase 3

New Capabilities

Rival developing an oral norovirus vaccine

Norovirus makes about 20 million Americans sick each year, and no vaccine has ever been approved to stop it. Moderna's shot is the furthest along. On July 31, 2026, the company said that shot fell short of the bar for early success in its big trial.

Updated 2 hours ago